| The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled … C Chaccour, A Casellas, A Blanco-Di Matteo, I Pineda, ... EClinicalMedicine 32, 2021 | 230 | 2021 |
| Decline in influenza vaccine effectiveness with time after vaccination, Navarre, Spain, season 2011/12 J Castilla, I Martínez-Baz, V Martínez-Artola, G Reina, F Pozo, MG Cenoz, ... Eurosurveillance 18 (5), 20388, 2013 | 148 | 2013 |
| Highly sensitive and specific multiplex antibody assays to quantify immunoglobulins M, A, and G against SARS-CoV-2 antigens C Dobaño, M Vidal, R Santano, A Jiménez, J Chi, D Barrios, G Ruiz-Olalla, ... Journal of clinical microbiology 59 (2), 10.1128/jcm. 01731-20, 2021 | 89 | 2021 |
| Immunogenicity and crossreactivity of antibodies to the nucleocapsid protein of SARS-CoV-2: utility and limitations in seroprevalence and immunity studies C Dobaño, R Santano, A Jiménez, M Vidal, J Chi, NR Melero, M Popovic, ... Translational Research 232, 60-74, 2021 | 88 | 2021 |
| New findings in HCV genotype distribution in selected West European, Russian and Israeli regions V Kartashev, M Döring, L Nieto, E Coletta, R Kaiser, S Sierra, A Guerrero, ... Journal of Clinical Virology 81, 82-89, 2016 | 86 | 2016 |
| Orthohepevirus C infection as an emerging cause of acute hepatitis in Spain: First report in Europe A Rivero-Juarez, M Frias, AB Perez, JA Pineda, G Reina, ... Journal of hepatology 77 (2), 326-331, 2022 | 70 | 2022 |
| Using NS5B sequencing for hepatitis C virus genotyping reveals discordances with commercial platforms N Chueca, I Rivadulla, R Lovatti, G Reina, A Blanco, ... PLoS One 11 (4), e0153754, 2016 | 45 | 2016 |
| Prevalence and distribution of hepatitis C virus genotypes in Spain during the 2000‐2015 period (the GEHEP 005 study) A Aguilera, D Navarro, F Rodríguez‐Frias, I Viciana, AM Martínez‐Sapiña, ... Journal of viral hepatitis 24 (9), 725-732, 2017 | 44 | 2017 |
| Effectiveness of subunit influenza vaccination in the 2014–2015 season and residual effect of split vaccination in previous seasons J Castilla, A Navascués, M Fernández-Alonso, G Reina, F Pozo, I Casado, ... Vaccine 34 (11), 1350-1357, 2016 | 44 | 2016 |
| Effectiveness of trivalent seasonal and monovalent influenza A (H1N1) 2009 vaccines in population with major chronic conditions of Navarre, Spain: 2010/11 mid-season analysis J Castilla, J Moran, V Martinez-Artola, G Reina, I Martinez-Baz, ... Eurosurveillance 16 (7), 2011 | 43 | 2011 |
| Effectiveness of the monovalent influenza A (H1N1) 2009 vaccine in Navarre, Spain, 2009–2010: cohort and case-control study J Castilla, J Morán, V Martínez-Artola, M Fernández-Alonso, M Guevara, ... Vaccine 29 (35), 5919-5924, 2011 | 41 | 2011 |
| Anti-mitochondrial M5 type antibody represents one of the serological markers for anti-phospholipid syndrome distinct from anti-cardiolipin and anti-β2-glycoprotein … L La Rosa, G Covini, C Galperin, L Catelli, N Del Papa, G Reina, ... Clinical & Experimental Immunology 112 (1), 144-151, 1998 | 40 | 1998 |
| Effectiveness of the trivalent influenza vaccine in Navarre, Spain, 2010–2011: a population-based test-negative case–control study I Martínez-Baz, V Martínez-Artola, G Reina, M Guevara, MG Cenoz, ... BMC Public Health 13, 1-8, 2013 | 38 | 2013 |
| Isolation of Mycoplasma hominis from extragenital cultures C Miranda, E Camacho, G Reina, J Turino, J Rodríguez-Granger, R Yeste, ... European Journal of Clinical Microbiology and Infectious Diseases 24, 334-337, 2005 | 36 | 2005 |
| The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in … C Chaccour, P Ruiz-Castillo, MA Richardson, G Moncunill, A Casellas, ... Trials 21, 1-4, 2020 | 30 | 2020 |
| Neutrophil extracellular traps, local IL-8 expression, and cytotoxic T-lymphocyte response in the lungs of patients with fatal COVID-19 I Melero, M Villalba-Esparza, B Recalde-Zamacona, D Jiménez-Sánchez, ... Chest 162 (5), 1006-1016, 2022 | 28 | 2022 |
| Vaccine effectiveness in preventing laboratory-confirmed influenza in Navarre, Spain: 2013/14 mid-season analysis J Castilla, I Martinez-Baz, A Navascués, M Fernandez-Alonso, G Reina, ... Eurosurveillance 19 (6), 20700, 2014 | 28 | 2014 |
| HTLV-1 infection in solid organ transplant donors and recipients in Spain C de Mendoza, L Roc, R Benito, G Reina, JM Ramos, C Gómez, ... BMC Infectious Diseases 19, 1-5, 2019 | 27 | 2019 |
| Primary Health Care Sentinel Network; Network for Influenza Surveillance in Hospitals of Navarre. Decline in influenza vaccine effectiveness with time after vaccination … J Castilla, I Martínez-Baz, V Martínez-Artola, G Reina, F Pozo, ... Euro Surveill 18 (5), 20388, 2013 | 27 | 2013 |
| Influenza outbreaks in nursing homes with high vaccination coverage in Navarre, Spain, 2011/12 J Castilla, F Cia, J Zubicoa, G Reina, V Martínez-Artola, C Ezpeleta Eurosurveillance 17 (14), 20141, 2012 | 26 | 2012 |
Federico Garcia GarciaHead of Clinical Microbiology UnitAdresă de e-mail confirmată pe ugr.es
